Reversible posterior leucoencephalopathy syndrome in an elderly male on sunitinib therapy

British Journal of Clinical Pharmacology

Volumn 71, Issue 5, 2011, Pages 777-779

  Padhy, Biswa M ^a   Shanmugam, Saravana P ^a   Gupta, Yogendra K ^a   Goyal, Aman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Causality assessment; Leucoencephalopathy; Sunitinib; Vascular endothelial growth factor

Indexed keywords

SUNITINIB;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MALE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PYRROLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953904526     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03893.x     Document Type: Article

References (8)

1. Jain R, Mathew P, Wood CG, Tannir NM. Sunitinib-induced acute hemolysis without hypertension: a case report. Clin Genitourin Cancer 2008; 6: 122-3.
2. Farcas A, Bojita M. Adverse drug reactions in clinical practice: a causality assessment of a case of drug-induced pancreatitis. J Gastrointestin Liver Dis 2009; 18: 353-8.
3. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007; 18: 1745-7.
4. Martín G, Bellido L, Cruz JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oncol 2007; 25: 3559.
5. Medioni J, Cojocarasu O, Banu E, Cassar-Queudeville A, Halimi P, Oudard S. Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient. Targ Oncol 2007; 2: 193-5.
6. Cumurciuc R, Martinez-Almoyna L, Henry C, Husson H, de Broucker T. Posterior reversible encephalopathy syndrome during sunitinib therapy. Rev Neurol (Paris) 2008; 164: 605-7.
7. Chen A, Agarwal N. Reversible posterior leucoencephalopathy syndrome associated with sunitinib. Intern Med J 2009; 39: 341-2.
8. Prescribing Information. Sutent® (sunitinib malate) oral capsules. Pfizer Inc. Available at (last accessed 5 November 2010).